New Ray Medicine International Holding (HKSE:06108) Ending Cash Position : HK$103.95 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding Ending Cash Position?

New Ray Medicine International Holding's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$103.95 Mil.

New Ray Medicine International Holding's quarterly Ending Cash Position declined from Dec. 2022 (HK$154.41 Mil) to Jun. 2023 (HK$112.45 Mil) and declined from Jun. 2023 (HK$112.45 Mil) to Dec. 2023 (HK$103.95 Mil).

New Ray Medicine International Holding's annual Ending Cash Position increased from Dec. 2021 (HK$150.15 Mil) to Dec. 2022 (HK$154.41 Mil) but then declined from Dec. 2022 (HK$154.41 Mil) to Dec. 2023 (HK$103.95 Mil).

New Ray Medicine International Holding Ending Cash Position Historical Data

The historical data trend for New Ray Medicine International Holding's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding Ending Cash Position Chart

New Ray Medicine International Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

88.67

65.76

150.15

154.41

103.95

New Ray Medicine International Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															150.15	151.89	154.41	112.45	103.95

New Ray Medicine International Holding Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

New Ray Medicine International Holding's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	154.413	+	-50.459
	=	103.95

New Ray Medicine International Holding's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	112.447	+	-8.493
	=	103.95

New Ray Medicine International Holding Ending Cash Position Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

New Ray Medicine International Holding (HKSE:06108) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN

Website

http://www.newraymedicine.com

New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.

Executives

Dai Xiaosong
Eagle Amber Holdings Limited
Chu Xueping	2201 Interest of corporation controlled by you
Qian Shenglei	2101 Beneficial owner
Zhang Jiang	2201 Interest of corporation controlled by you
Yang Fang	2202 Interest of your spouse
Zhou Ling	2101 Beneficial owner

New Ray Medicine International Holding (HKSE:06108) Headlines

No Headlines